nodes	percent_of_prediction	percent_of_DWPC	metapath
Vecuronium—ABCB1—Mitomycin—stomach cancer	0.438	0.581	CbGbCtD
Vecuronium—ABCB1—Irinotecan—stomach cancer	0.112	0.149	CbGbCtD
Vecuronium—ABCB1—Docetaxel—stomach cancer	0.0823	0.109	CbGbCtD
Vecuronium—ABCB1—Doxorubicin—stomach cancer	0.0613	0.0814	CbGbCtD
Vecuronium—ABCB1—Methotrexate—stomach cancer	0.0594	0.0789	CbGbCtD
Vecuronium—Injection site reaction—Mitomycin—stomach cancer	0.0105	0.0424	CcSEcCtD
Vecuronium—Erythema—Floxuridine—stomach cancer	0.00587	0.0238	CcSEcCtD
Vecuronium—Anaphylactic shock—Floxuridine—stomach cancer	0.00479	0.0194	CcSEcCtD
Vecuronium—Nervous system disorder—Floxuridine—stomach cancer	0.0047	0.019	CcSEcCtD
Vecuronium—Redness—Docetaxel—stomach cancer	0.00468	0.019	CcSEcCtD
Vecuronium—Erythema—Mitomycin—stomach cancer	0.0046	0.0187	CcSEcCtD
Vecuronium—Rash erythematous—Docetaxel—stomach cancer	0.00413	0.0167	CcSEcCtD
Vecuronium—Rash erythematous—Capecitabine—stomach cancer	0.004	0.0162	CcSEcCtD
Vecuronium—Injection site pain—Capecitabine—stomach cancer	0.00375	0.0152	CcSEcCtD
Vecuronium—Shock—Mitomycin—stomach cancer	0.0037	0.015	CcSEcCtD
Vecuronium—Hypersensitivity—Floxuridine—stomach cancer	0.00353	0.0143	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Irinotecan—stomach cancer	0.00343	0.0139	CcSEcCtD
Vecuronium—Paralysis—Methotrexate—stomach cancer	0.00328	0.0133	CcSEcCtD
Vecuronium—Respiratory failure—Docetaxel—stomach cancer	0.00322	0.013	CcSEcCtD
Vecuronium—Redness—Epirubicin—stomach cancer	0.00316	0.0128	CcSEcCtD
Vecuronium—Injection site reaction—Docetaxel—stomach cancer	0.00314	0.0127	CcSEcCtD
Vecuronium—Paralysis—Epirubicin—stomach cancer	0.00307	0.0124	CcSEcCtD
Vecuronium—Injection site reaction—Capecitabine—stomach cancer	0.00304	0.0123	CcSEcCtD
Vecuronium—Rash—Floxuridine—stomach cancer	0.00302	0.0122	CcSEcCtD
Vecuronium—Dermatitis—Floxuridine—stomach cancer	0.00302	0.0122	CcSEcCtD
Vecuronium—Redness—Doxorubicin—stomach cancer	0.00292	0.0118	CcSEcCtD
Vecuronium—Paralysis—Doxorubicin—stomach cancer	0.00284	0.0115	CcSEcCtD
Vecuronium—Muscular weakness—Fluorouracil—stomach cancer	0.00281	0.0114	CcSEcCtD
Vecuronium—Rash erythematous—Epirubicin—stomach cancer	0.00279	0.0113	CcSEcCtD
Vecuronium—Apnoea—Methotrexate—stomach cancer	0.00269	0.0109	CcSEcCtD
Vecuronium—Injection site pain—Epirubicin—stomach cancer	0.00261	0.0106	CcSEcCtD
Vecuronium—Rash erythematous—Doxorubicin—stomach cancer	0.00258	0.0104	CcSEcCtD
Vecuronium—Injection site pain—Doxorubicin—stomach cancer	0.00242	0.00979	CcSEcCtD
Vecuronium—Rash—Mitomycin—stomach cancer	0.00237	0.0096	CcSEcCtD
Vecuronium—Dermatitis—Mitomycin—stomach cancer	0.00237	0.00959	CcSEcCtD
Vecuronium—Respiratory failure—Methotrexate—stomach cancer	0.00232	0.0094	CcSEcCtD
Vecuronium—Connective tissue disorder—Irinotecan—stomach cancer	0.00226	0.00915	CcSEcCtD
Vecuronium—Face oedema—Capecitabine—stomach cancer	0.00215	0.00869	CcSEcCtD
Vecuronium—Cardiac disorder—Irinotecan—stomach cancer	0.00213	0.00864	CcSEcCtD
Vecuronium—Flushing—Irinotecan—stomach cancer	0.00213	0.00864	CcSEcCtD
Vecuronium—Injection site reaction—Epirubicin—stomach cancer	0.00212	0.00859	CcSEcCtD
Vecuronium—Angiopathy—Irinotecan—stomach cancer	0.00208	0.00845	CcSEcCtD
Vecuronium—Immune system disorder—Irinotecan—stomach cancer	0.00208	0.00841	CcSEcCtD
Vecuronium—Mediastinal disorder—Irinotecan—stomach cancer	0.00207	0.00839	CcSEcCtD
Vecuronium—Injection site reaction—Doxorubicin—stomach cancer	0.00196	0.00795	CcSEcCtD
Vecuronium—Muscular weakness—Capecitabine—stomach cancer	0.00196	0.00794	CcSEcCtD
Vecuronium—Bronchospasm—Docetaxel—stomach cancer	0.00195	0.00791	CcSEcCtD
Vecuronium—Erythema—Fluorouracil—stomach cancer	0.00192	0.00776	CcSEcCtD
Vecuronium—Bronchospasm—Capecitabine—stomach cancer	0.00189	0.00766	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Methotrexate—stomach cancer	0.00171	0.00693	CcSEcCtD
Vecuronium—Anaphylactic shock—Irinotecan—stomach cancer	0.00163	0.00661	CcSEcCtD
Vecuronium—Shock—Irinotecan—stomach cancer	0.00161	0.00651	CcSEcCtD
Vecuronium—Nervous system disorder—Irinotecan—stomach cancer	0.0016	0.00649	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Epirubicin—stomach cancer	0.0016	0.00648	CcSEcCtD
Vecuronium—Anaphylactic shock—Fluorouracil—stomach cancer	0.00156	0.00633	CcSEcCtD
Vecuronium—Connective tissue disorder—Docetaxel—stomach cancer	0.00156	0.00632	CcSEcCtD
Vecuronium—Nervous system disorder—Fluorouracil—stomach cancer	0.00153	0.00621	CcSEcCtD
Vecuronium—Tachycardia—Fluorouracil—stomach cancer	0.00153	0.00618	CcSEcCtD
Vecuronium—Hypotension—Irinotecan—stomach cancer	0.00153	0.00618	CcSEcCtD
Vecuronium—Connective tissue disorder—Capecitabine—stomach cancer	0.00151	0.00612	CcSEcCtD
Vecuronium—Face oedema—Epirubicin—stomach cancer	0.00149	0.00606	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Doxorubicin—stomach cancer	0.00148	0.006	CcSEcCtD
Vecuronium—Cardiac disorder—Docetaxel—stomach cancer	0.00147	0.00597	CcSEcCtD
Vecuronium—Flushing—Docetaxel—stomach cancer	0.00147	0.00597	CcSEcCtD
Vecuronium—Hypotension—Fluorouracil—stomach cancer	0.00146	0.00592	CcSEcCtD
Vecuronium—Angiopathy—Docetaxel—stomach cancer	0.00144	0.00584	CcSEcCtD
Vecuronium—Immune system disorder—Docetaxel—stomach cancer	0.00143	0.00581	CcSEcCtD
Vecuronium—Mediastinal disorder—Docetaxel—stomach cancer	0.00143	0.0058	CcSEcCtD
Vecuronium—Flushing—Capecitabine—stomach cancer	0.00143	0.00578	CcSEcCtD
Vecuronium—Cardiac disorder—Capecitabine—stomach cancer	0.00143	0.00578	CcSEcCtD
Vecuronium—Angiopathy—Capecitabine—stomach cancer	0.00139	0.00565	CcSEcCtD
Vecuronium—Immune system disorder—Capecitabine—stomach cancer	0.00139	0.00563	CcSEcCtD
Vecuronium—Mediastinal disorder—Capecitabine—stomach cancer	0.00139	0.00561	CcSEcCtD
Vecuronium—Face oedema—Doxorubicin—stomach cancer	0.00138	0.0056	CcSEcCtD
Vecuronium—Erythema—Docetaxel—stomach cancer	0.00138	0.0056	CcSEcCtD
Vecuronium—Muscular weakness—Epirubicin—stomach cancer	0.00137	0.00553	CcSEcCtD
Vecuronium—Erythema—Capecitabine—stomach cancer	0.00134	0.00542	CcSEcCtD
Vecuronium—Muscular weakness—Doxorubicin—stomach cancer	0.00126	0.00512	CcSEcCtD
Vecuronium—Urticaria—Fluorouracil—stomach cancer	0.00124	0.00503	CcSEcCtD
Vecuronium—Hypersensitivity—Irinotecan—stomach cancer	0.0012	0.00487	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.00117	0.00474	CcSEcCtD
Vecuronium—Hypersensitivity—Fluorouracil—stomach cancer	0.00115	0.00467	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.00113	0.00459	CcSEcCtD
Vecuronium—Anaphylactic shock—Docetaxel—stomach cancer	0.00113	0.00457	CcSEcCtD
Vecuronium—Shock—Docetaxel—stomach cancer	0.00111	0.0045	CcSEcCtD
Vecuronium—Nervous system disorder—Docetaxel—stomach cancer	0.00111	0.00448	CcSEcCtD
Vecuronium—Tachycardia—Docetaxel—stomach cancer	0.0011	0.00446	CcSEcCtD
Vecuronium—Skin disorder—Docetaxel—stomach cancer	0.0011	0.00444	CcSEcCtD
Vecuronium—Shock—Capecitabine—stomach cancer	0.00107	0.00435	CcSEcCtD
Vecuronium—Nervous system disorder—Capecitabine—stomach cancer	0.00107	0.00434	CcSEcCtD
Vecuronium—Tachycardia—Capecitabine—stomach cancer	0.00107	0.00432	CcSEcCtD
Vecuronium—Cardiac disorder—Methotrexate—stomach cancer	0.00106	0.0043	CcSEcCtD
Vecuronium—Skin disorder—Capecitabine—stomach cancer	0.00106	0.0043	CcSEcCtD
Vecuronium—Hypotension—Docetaxel—stomach cancer	0.00105	0.00427	CcSEcCtD
Vecuronium—Connective tissue disorder—Epirubicin—stomach cancer	0.00105	0.00426	CcSEcCtD
Vecuronium—Angiopathy—Methotrexate—stomach cancer	0.00104	0.00421	CcSEcCtD
Vecuronium—Immune system disorder—Methotrexate—stomach cancer	0.00103	0.00419	CcSEcCtD
Vecuronium—Mediastinal disorder—Methotrexate—stomach cancer	0.00103	0.00418	CcSEcCtD
Vecuronium—Rash—Irinotecan—stomach cancer	0.00103	0.00417	CcSEcCtD
Vecuronium—Dermatitis—Irinotecan—stomach cancer	0.00103	0.00417	CcSEcCtD
Vecuronium—Hypotension—Capecitabine—stomach cancer	0.00102	0.00414	CcSEcCtD
Vecuronium—Erythema—Methotrexate—stomach cancer	0.000996	0.00404	CcSEcCtD
Vecuronium—Flushing—Epirubicin—stomach cancer	0.000994	0.00403	CcSEcCtD
Vecuronium—Cardiac disorder—Epirubicin—stomach cancer	0.000994	0.00403	CcSEcCtD
Vecuronium—Rash—Fluorouracil—stomach cancer	0.000986	0.00399	CcSEcCtD
Vecuronium—Dermatitis—Fluorouracil—stomach cancer	0.000985	0.00399	CcSEcCtD
Vecuronium—Connective tissue disorder—Doxorubicin—stomach cancer	0.000974	0.00395	CcSEcCtD
Vecuronium—Angiopathy—Epirubicin—stomach cancer	0.000972	0.00394	CcSEcCtD
Vecuronium—Immune system disorder—Epirubicin—stomach cancer	0.000968	0.00392	CcSEcCtD
Vecuronium—Mediastinal disorder—Epirubicin—stomach cancer	0.000965	0.00391	CcSEcCtD
Vecuronium—Erythema—Epirubicin—stomach cancer	0.000932	0.00378	CcSEcCtD
Vecuronium—Flushing—Doxorubicin—stomach cancer	0.00092	0.00373	CcSEcCtD
Vecuronium—Cardiac disorder—Doxorubicin—stomach cancer	0.00092	0.00373	CcSEcCtD
Vecuronium—Angiopathy—Doxorubicin—stomach cancer	0.000899	0.00364	CcSEcCtD
Vecuronium—Immune system disorder—Doxorubicin—stomach cancer	0.000895	0.00363	CcSEcCtD
Vecuronium—Mediastinal disorder—Doxorubicin—stomach cancer	0.000893	0.00362	CcSEcCtD
Vecuronium—Urticaria—Capecitabine—stomach cancer	0.000868	0.00352	CcSEcCtD
Vecuronium—Erythema—Doxorubicin—stomach cancer	0.000863	0.0035	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000842	0.00341	CcSEcCtD
Vecuronium—Hypersensitivity—Docetaxel—stomach cancer	0.000831	0.00337	CcSEcCtD
Vecuronium—Anaphylactic shock—Methotrexate—stomach cancer	0.000813	0.00329	CcSEcCtD
Vecuronium—Hypersensitivity—Capecitabine—stomach cancer	0.000805	0.00326	CcSEcCtD
Vecuronium—Nervous system disorder—Methotrexate—stomach cancer	0.000797	0.00323	CcSEcCtD
Vecuronium—Skin disorder—Methotrexate—stomach cancer	0.00079	0.0032	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000788	0.00319	CcSEcCtD
Vecuronium—Anaphylactic shock—Epirubicin—stomach cancer	0.000761	0.00308	CcSEcCtD
Vecuronium—Hypotension—Methotrexate—stomach cancer	0.00076	0.00308	CcSEcCtD
Vecuronium—Shock—Epirubicin—stomach cancer	0.000749	0.00303	CcSEcCtD
Vecuronium—Nervous system disorder—Epirubicin—stomach cancer	0.000746	0.00302	CcSEcCtD
Vecuronium—Tachycardia—Epirubicin—stomach cancer	0.000743	0.00301	CcSEcCtD
Vecuronium—Skin disorder—Epirubicin—stomach cancer	0.000739	0.003	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000729	0.00296	CcSEcCtD
Vecuronium—Rash—Docetaxel—stomach cancer	0.000711	0.00288	CcSEcCtD
Vecuronium—Hypotension—Epirubicin—stomach cancer	0.000711	0.00288	CcSEcCtD
Vecuronium—Dermatitis—Docetaxel—stomach cancer	0.000711	0.00288	CcSEcCtD
Vecuronium—Anaphylactic shock—Doxorubicin—stomach cancer	0.000704	0.00285	CcSEcCtD
Vecuronium—Shock—Doxorubicin—stomach cancer	0.000693	0.00281	CcSEcCtD
Vecuronium—Nervous system disorder—Doxorubicin—stomach cancer	0.000691	0.0028	CcSEcCtD
Vecuronium—Rash—Capecitabine—stomach cancer	0.000689	0.00279	CcSEcCtD
Vecuronium—Dermatitis—Capecitabine—stomach cancer	0.000688	0.00279	CcSEcCtD
Vecuronium—Tachycardia—Doxorubicin—stomach cancer	0.000687	0.00278	CcSEcCtD
Vecuronium—Skin disorder—Doxorubicin—stomach cancer	0.000684	0.00277	CcSEcCtD
Vecuronium—Hypotension—Doxorubicin—stomach cancer	0.000658	0.00267	CcSEcCtD
Vecuronium—Urticaria—Methotrexate—stomach cancer	0.000646	0.00262	CcSEcCtD
Vecuronium—Urticaria—Epirubicin—stomach cancer	0.000605	0.00245	CcSEcCtD
Vecuronium—Hypersensitivity—Methotrexate—stomach cancer	0.000599	0.00243	CcSEcCtD
Vecuronium—Hypersensitivity—Epirubicin—stomach cancer	0.000561	0.00227	CcSEcCtD
Vecuronium—Urticaria—Doxorubicin—stomach cancer	0.000559	0.00227	CcSEcCtD
Vecuronium—Hypersensitivity—Doxorubicin—stomach cancer	0.000519	0.0021	CcSEcCtD
Vecuronium—Rash—Methotrexate—stomach cancer	0.000513	0.00208	CcSEcCtD
Vecuronium—Dermatitis—Methotrexate—stomach cancer	0.000512	0.00208	CcSEcCtD
Vecuronium—Rash—Epirubicin—stomach cancer	0.00048	0.00194	CcSEcCtD
Vecuronium—Dermatitis—Epirubicin—stomach cancer	0.000479	0.00194	CcSEcCtD
Vecuronium—Rash—Doxorubicin—stomach cancer	0.000444	0.0018	CcSEcCtD
Vecuronium—Dermatitis—Doxorubicin—stomach cancer	0.000444	0.0018	CcSEcCtD
